Skip to main content
Caplight Logo









Serenis

Serenis

Private
MilanHealthcare & Life Scienceshttps://www.serenis.it/

Last Round

Series A

Sep 29, 2025

Total Funding Raised

$19.64M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Serenis is a digital health company that provides an online platform for mental health services, including psychotherapy, psychiatry, nutrition, and coaching.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, HR

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

online psychotherapytelemedicinemental health supportteletherapyemployee well-beingEAPemployee assistance programdigital healthremote counselingcorporate mental healthmental health benefitsgenerative AIAI scribe

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Serenis Comparables

Compare Serenis with similar companies based on industry and business-model similarity.

Serenis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Unobravo
89%
Therapyside
84%
Sygmund
80%

Serenis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 29, 2025
SeedNov 10, 2022
Pre SeedFeb 8, 2022

Key People

Founding team and executive leadership

Silvia Wang

Co-Founder CEO

Founding Team

Serena Rossetti

CFO

Executive Team

Ettore Penazzato

COO

Executive Team

Carlo Alberto Gaetaniello

Chief Product Officer, Director Of Business Development

Executive Team

Serenis Investors

Notable investors and investment history

Serenis investors
InvestorRounds
Azimut Libera Impresa SGRSeed, Series A
FG2 CapitalSeries A, Seed
Club degli InvestitoriSeries A
Invictus Capital Partners (Singapore)Seed, Series A
Lumen VenturesSeed, Series A
Angelini VenturesSeed, Series A
CDP Venture Capital SGRSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2026

    New service for adult ADHD diagnosis launched in May 2026.

  • Dec 22, 2025

    Added Unifarco S.p.A. from the Pharmaceuticals/Cosmetics industry.

Serenis Filings

Explore SEC and related filing metadata, where available.

Serenis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Serenis's valuation, stock price, and market status.

Is Serenis a public or private company?

Serenis is a private company.

What is the current stock price of Serenis?

Serenis is a private company with no public stock price. No recent secondary market data is available.

How much is Serenis worth (valuation)?

Valuation information for Serenis is not publicly available.

Can I buy Serenis stock?

Serenis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Serenis's last funding round?

Serenis's most recent funding round was Series A on September 29, 2025.

Who are the main investors in Serenis?

Key investors in Serenis include FG2 Capital, Angelini Ventures, CDP Venture Capital SGR.

Will Serenis IPO soon?

No public IPO plans have been announced for Serenis.

How can I track Serenis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Serenis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMilan
Employee Range623
Year Founded2021
Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?